基层医生可综合管理睡眠呼吸暂停患者:一项非劣效性随机对照试验
本研究为多中心非劣效性随机对照试验,在西班牙六家三级医院纳入307例中高度阻塞性睡眠呼吸暂停(OSA)概率患者,比较基层健康区(PHA)管理与实验室专科管理6个月随访的效果。基于Epworth嗜睡量表,PHA方案非劣效于实验室方案,次要结局相似,且PHA组每人成本低537.8欧元。
要点
- 对于中高度OSA概率患者,基层管理在改善嗜睡方面非劣效于实验室专科管理。
- 基层管理方案采用便携监测仪自动评分和半自动治疗决策,可降低医疗成本。
- 两组在生活质量、血压、心血管事件、CPAP依从性等次要结局上相似。
核心结论
- 基层健康区管理可作为中高度OSA概率患者实验室专科管理的替代方案。
- 鉴于门诊管理明确的经济优势,该发现可能改变现有临床实践。
研究设计与样本
- 多中心、非劣效性、随机、对照试验,两组开放平行,并包含成本效果分析。
- 在西班牙六家三级医院连续筛查中高度OSA概率患者,随机分配至PHA组或实验室组。
- 共307例患者随机化,303例纳入意向性治疗分析。
- PHA组采用便携监测仪自动评分和半自动治疗决策;实验室组采用多导睡眠图和专科治疗决策。
- 两组患者均接受持续气道正压通气治疗或仅睡眠卫生和饮食治疗。
主要发现
- 主要结局Epworth嗜睡量表显示PHA方案非劣效于实验室方案。
- 次要结局变量在两种方案间相似。
- 成本效果关系有利于PHA组,每人成本差异为537.8欧元。
关键数值与推荐
- 主要结局为Epworth嗜睡量表。
- 次要结局包括健康相关生活质量、血压、心血管事件发生率、医院资源利用、CPAP依从性和试验内成本。
- PHA方案非劣效于实验室方案(基于Epworth嗜睡量表)。
- PHA组每人成本低537.8欧元。
临床怎么用
- 对于中高度OSA概率患者,可考虑在基层健康区采用便携监测仪自动评分和半自动治疗决策进行管理。
- 基层管理可能降低医疗成本,但需结合当地资源配置和培训情况实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: General practitioners play a passive role in obstructive sleep apnea (OSA) management. Simplification of the diagnosis and use of a semiautomatic algorithm for treatment can facilitate the integration of general practitioners, which has cost advantages.Objectives: To determine differences in effectiveness between primary health care area (PHA) and in-laboratory specialized management protocols during 6 months of follow-up.Methods: A multicenter, noninferiority, randomized, controlled trial with two open parallel arms and a cost-effectiveness analysis was performed in six tertiary hospitals in Spain. Sequentially screened patients with an intermediate to high OSA probability were randomized to PHA or in-laboratory management. The PHA arm involved a portable monitor with automatic scoring and semiautomatic therapeutic decision-making. The in-laboratory arm included polysomnography and specialized therapeutic decision-making. Patients in both arms received continuous positive airway pressure treatment or sleep hygiene and dietary treatment alone. The primary outcome measure was the Epworth Sleepiness Scale. Secondary outcomes were health-related quality of life, blood pressure, incidence of cardiovascular events, hospital resource utilization, continuous positive airway pressure adherence, and within-trial costs.Measurements and Main Results: In total, 307 patients were randomized and 303 were included in the intention-to-treat analysis. Based on the Epworth Sleepiness Scale, the PHA protocol was noninferior to the in-laboratory protocol. Secondary outcome variables were similar between the protocols. The cost-effectiveness relationship favored the PHA arm, with a cost difference of €537.8 per patient.Conclusions: PHA management may be an alternative to in-laboratory management for patients with an intermediate to high OSA probability. Given the clear economic advantage of outpatient management, this finding could change established clinical practice.Clinical trial registered with www.clinicaltrials.gov (NCT02141165).
引用
- Sánchez-Quiroga MÁ, Corral J, Gómez-de-Terreros FJ, et al. Primary Care Physicians Can Comprehensively Manage Patients with Sleep Apnea. A Noninferiority Randomized Controlled Trial. Am J Respir Crit Care Med. 2018. PMID: 29664672. doi:10.1164/rccm.201710-2061OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。